Altered expression of endothelin and its receptors in the brain of SHR-SP at malignant hypertensive stage

Journal of Cardiovascular Pharmacology

Volumn 44, Issue SUPPL. 1, 2004, Pages

  Jesmin, Subrina ^a   Sakuma, Ichiro ^a   Togashi, Hiroko ^a   Yamaguchi, Taku ^a   Ueno, Ken Ichi ^a   Yoshioka, Mitsuhiro ^a   Hattori, Yuichi ^a   Kitabatake, Akira ^a   Miyauchi, Takashi ^b  

^a HOKKAIDO UNIVERSITY   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Cerebral blood flow; Endothelin and its receptors; Malignant hypertension; SHR SP

Indexed keywords

ENDOTHELIN; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; ENDOTHELIN B RECEPTOR; ENDOTHELIN RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BRAIN BLOOD FLOW; BRAIN REGION; BRAIN TISSUE; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE PREDISPOSITION; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FRONTAL CORTEX; GENE CONTROL; MALE; MALIGNANT HYPERTENSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RECEPTOR UPREGULATION; SPONTANEOUSLY HYPERTENSIVE RAT; STROKE;

AGE FACTORS; ANIMALS; BLOOD FLOW VELOCITY; CEREBRAL CORTEX; CEREBROVASCULAR CIRCULATION; DISEASE MODELS, ANIMAL; DOWN-REGULATION; ENDOTHELIN-1; HYPERTENSION; MALE; RATS; RATS, INBRED SHR; RATS, INBRED WKY; RECEPTOR, ENDOTHELIN A; RECEPTOR, ENDOTHELIN B; STROKE; UP-REGULATION;

EID: 11144252843     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.fjc.0000166224.57970.91     Document Type: Conference Paper

References (27)

1. Okamoto K, Yamori Y, Nagaoka A. Establishment of the stroke-prone spontaneously hypertensive rat (SHR). Circ Res. 1974;33/34:I-143-I-53.
2. Kawashima K, Shiono K, Sokabe H. Variation of plasma and kidney renin activities among substrains of spontaneously hypertensive rats. Clin Exp Hypertens. 1980;2:229-245.
3. Ogata J, Fujishima M, Tamaki K, et al. Stroke-prone spontaneously hypertensive rats as an experimental model of malignant hypertension. A pathological study. Virchows Arch. 1982;394:185-1941
4. Ogata J, Fujishima M, Tamaki K, et al. Stroke-prone spontaneously hypertensive rats as an experimental model of malignant hypertension. I. A light- and electron-microscopic study of the brain. Acta Neuropathol (Berl). 1980;51:179-184.
5. Graham DI. Morphologic changes during hypertension. Am J Cardiol. 1989;63:6C-9C.
6. Schiffrin EL. Endothelin in hypertension. Curr Opin Cardiol. 1995;10:485-494.
7. Kohno M, Murakawa K, Horio T, et al. Plasma immunoreactive endothelin-1 in experimental malignant hypertension. Hypertension. 1991;18:93-100.
8. Stasch JP, Hirth-Dietrich C, Frobel K, et al. Prolonged endothelin blockade prevents hypertension and cardiac hypertrophy in stroke-prone spontaneously hypertensive rats. Am J Hypertens. 1995;8:1128-1134.
9. Nishikibe M, Tsuchida S, Okada M, et al. Antihypertensive effect of a newly synthesized endothelin antagonist, BQ-123, in a genetic hypertensive model. Life Sci. 1993;52:717-724.
10. Savage P, Jeng AY. Upregulation of endothelin-1 binding in tissues of salt-loaded stroke-prone spontaneously hypertensive rats. Can J Physiol Pharmacol. 2002;80:470-474.
11. Greenberg BH. Endothelin and endothelin receptor antagonists in heart failure. Congest Heart Fail. 2002;8:257-261.
12. Kunimatsu T, Asai S, Kanematsu K, et al. Effects of glutamate receptor agonist on extracellular glutamate dynamics during moderate cerebral ischemia. Brain Res. 2001;923:178-186.
13. Namura S, Iihara K, Takami S, et al. Intravenous administration of MEK inhibitor U0126 affords brain protection against forebrain ischemia and focal cerebral ischemia. Proc Natl Acad Sci U S A. 2001;98:11569-11574.
14. Yamori Y, Hone R. Developmental course of hypertension and regional cerebral blood flow in stroke-prone spontaneously hypertensive rats. Stroke. 1977;8:456-461.
15. Baumbach GL, Heistad DD. Remodeling of cerebral arterioles in chronic hypertension. Hypertension. 1989;13:968-972.
16. Hajdu MA, Heistad DD, Baumbach GL. Effects of antihypertensive treatment on mechanics of cerebral arterioles in rats. Hypertension. 1991;17:308-316.
17. Baumbach GL, Hajdu MA. Mechanics and composition of cerebral arterioles in renal and spontaneously hypertensive rats. Hypertension. 1993;21:816-826.
18. Takahashi M, Fritz-Zieroth B, Ohta Y, et al. Therapeutic effects of imidapril on cerebral lesions observed by magnetic resonance imaging in malignant stroke-prone spontaneously hypertensive rats. J Hypertens. 1994;12:761-768.
19. Bennai F, Morsing P, Paliege A, et al. Normalizing the expression of nitric oxide synthase by low-dose AT1 receptor antagonism parallels improved vascular morphology in hypertensive rats. J Am Soc Nephrol. 1999;10:S104-S115.
20. Li JS, Larivière R, Schiffrin EL. Effect of a nonselective endothelin antagonist on vascular remodeling in deoxycorticosterone acetate-salt hypertensive rats: evidence for a role of endothelin in vascular hypertrophy. Hypertension. 1994;24:183-188.
21. Armstead WM. ET-1 contributes to age-dependent G protein impairment after brain injury. J Neurotrauma. 2003;20:105-110.
22. Noguchi T, Sasaki Y, Seki J, et al. Enhanced thrombogenicity and altered hemodynamics in the cerebral microvasculature of stroke-prone spontaneously hypertensive rats. Haemostasis. 1997;27:237-245.
23. Blezer EL, Nicolay K, Goldschmeding R, et al. Early-onset but not late-onset endothelin-A-receptor blockade can modulate hypertension, cerebral edema, and proteinuria in stroke-prone hypertensive rats. Hypertension. 1999;33:137-144.
24. Seo B, Oemar BS, Siebenmann R, et al. Both ETA and ETB receptors mediate contraction to endothelin-1 in human blood vessels. Circulation. 1994;89:1203-1208.
25. Gariepy, CE, Ohuchi T, Williams SC, et al. Salt-sensitive hypertension in endothelin-B receptor-deficient rats. J Clin Invest. 2000;105:925-33.
26. B receptors in rats. Biochem Biophys Res Commun. 1994;199:1461-1465.
27. Zhang Y, Zou Y, Xu M, et al. Effect of endothelin and endothelin A receptors on regional cerebral blood flow after traumatic brain injury in rabbits. Chin J Traumatol. 2000;3:185-8.